Publications
1. SIMA, L., FILIMON,A., PITICESCU, R.M., CHITANU, G.C., SUFLET, D.M., MIROIU, M., SOCOL,G., MIHAILESCU, I.N., NEAMTU, J., NEGROIU, G. Specific biofunctional performances of the hydroxyapatite-sodium maleate copolymer hybrid coating nanostructures evaluated by in vitro studies J.Mat.Sci: Mat in Med. 20, 2305-2316, 2009.
2. NEGROIU, G., PITICESCU, R.M., CHITANU, G.C., MIHAILESCU, I.N., ZDRENTU, L., MIROIU, M. Biocompatibility evaluation of a novel hydroxyapatite-polymer coatingfor medical implants (in vitro tests). J.Mat.Sci. Mat. in Med 19, 4, 1537-1544, 2008.
3. PITICESCU, R.M., CHITANU, G.C., MEGHEA, A., GURGINCA, M.,
NEGROIU, G., POPESCU, L.M. Comparative study of in situ interactions between maleic anhydride based copolymers with hydroxyapatite Key Engineering Materials 361-363, 387-390, 2008.
4. NEGROIU, G., DWEK, R.A., PETRESCU, S.M. Tyrosinase Related Protein-2 and -1 are trafficked on distinct routes in B16 melanoma cells Biochem. Biophys. Res. Commun. 328, 914-921, 2005.
5. NEEFT M, WIEFFER M, DE JONG AS, NEGROIU G, METZ CH, VAN LOON A, GRIFFITH J, KRIJGSVELD J, WULFFRAAT N, KOCH H, HECK AJ, BROSE N, KLEIJMEER M, VAN DER SLUIJS P. Munc13-4 is an effector of rab27a and controls secretion of lysosomes in hematopoietic cells.Mol Biol Cell. 16, 731-741, 2005.
6. NEGROIU, G., DWEK, R.A., PETRESCU, S.M. The inhibition of early N-glycan processing targets TRP-2 to degradation in B16 melanoma cells J.Biol.Chem. 278, 29, 27035-27042, 2003.
